Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Developing tests for precise diagnosis of age-related hearing loss

Official title: Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss

Run by Institut Pasteur · NCT05312983 · Data updated 2026-11-12

This study is testing new hearing tests to better diagnose age-related hearing loss in older adults so they can get the right treatment sooner.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment700 (estimated)
SponsorInstitut Pasteur
Industry-sponsored
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedJuly 28, 2022
Main results expectedDecember 31, 2027
Study endsDecember 31, 2030
Registry record updatedMarch 3, 2025
Trial IDNCT05312983 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals over 40 with anticipated presbycusis or those aged 18-40 with a progressive genetic hearing defect.

Probably not a fit

Patients with chronic exposure to loud sounds, history of ototoxic substance use, or other significant ear-related health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a comprehensive battery of audiological tests to accurately diagnose age-related hearing loss, known as presbycusis. It involves a multi-center, non-invasive case-control study with 700 participants, including 500 individuals with anticipated presbycusis and 200 healthy controls. Participants will undergo extensive audiological, vestibular, and neurocognitive assessments over multiple visits, along with genetic analysis through blood sampling. The goal is to enhance early identification and treatment of hearing loss through tailored hearing aid adjustments.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses and personalized treatment plans for patients with age-related hearing loss.

How similar studies have gone: Other studies have shown promise in developing diagnostic tools for hearing loss, but this approach is innovative in its focus on precision diagnosis through a comprehensive test battery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For all participants:

* Be over the age of 18,
* Be affiliated to a social security system,
* Have a good command of the French language (oral and written).

For the group of participants with anticipated presbycusis:

* Over the age of 40, having a hearing aid recipient or coming for a first hearing aid recipient
* Between 18 and 40, having a hearing aid recipient, coming for a first hearing aid recipient or declare a progressive genetic birth defect

For healthy volunteers:

\- Have no known hearing loss.

Exclusion Criteria:

* Report having been chronically exposed to loud sounds.
* Have a history of ototoxic substances,
* To have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing or balance,
* Have an ethnic origin for which the Pasteur Institute does not have information on the frequency of variants of the genes studied.
* Have type II diabetes,
* Have a neurological or psychiatric condition that interferes with comprehension or ability to move,
* Be under guardianship,
* Be deprived of liberty by judicial or administrative decision, or be subject to legal protection,
* Not being subject to a social security system,
* Taking narcotic substances, alcohol or medication that diminishes cognitive abilities.

Where it's running

  • CEntre de Recherche et d'Innovation en Audiologie Humaine
    Paris, France
    Recruiting
  • Laboratoire de correction auditive
    Paris, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • MOPEVAC-Las vaccine in healthy adults to test safety and immune response for Lassa fever

    A small study in healthy adults checks if MOPEVAC-Las is safe and can trigger an immune response, trying different dose levels.

    Recruiting Phase 1 Institut Pasteur · Paris · NCT07833436

  • Testing for viruses after a monkey bite

    We will test adults who were recently bitten by a monkey or who have a history of monkey bites to see if they carry simian viruses such as STLV-1 or SFV using blood and saliva samples.

    Recruiting Institut Pasteur · Paris · NCT07097480

  • Speech therapy to improve lip-reading for people who use hearing aids

    This will see if speech therapy for lip-reading improves visual speech recognition in adults with moderate-to-severe hearing loss who wear hearing aids.

    Recruiting Institut Pasteur · Paris · NCT07028658

  • How breast milk affects virus infectivity and transmission

    This project will test whether components of donated breast milk change how viruses such as HTLV-1, Zika, dengue, yellow fever, and tick-borne encephalitis infect cells and could affect transmission.

    Recruiting Institut Pasteur · Paris · NCT06738563

  • Exploring immune responses to yellow fever vaccination

    This study is testing whether yellow fever and typhoid vaccines can boost the immune system's ability to fight off other infections, and it involves collecting blood samples from participants after they get vaccinated.

    Recruiting Institut Pasteur · Paris · NCT06718127

  • Observing health issues faced by travelers

    This study is trying to find out how often travelers get sick when visiting emerging countries and what factors might increase their risk, so we can give better advice to help keep them healthy.

    Recruiting Institut Pasteur · Paris · NCT06701890

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.